200 related articles for article (PubMed ID: 15757496)
1. Development of a size-dependent aerosol deposition model utilising human airway epithelial cells for evaluating aerosol drug delivery.
Cooney D; Kazantseva M; Hickey AJ
Altern Lab Anim; 2004 Dec; 32(6):581-90. PubMed ID: 15757496
[TBL] [Abstract][Full Text] [Related]
2. The permeability of large molecular weight solutes following particle delivery to air-interfaced cells that model the respiratory mucosa.
Grainger CI; Greenwell LL; Martin GP; Forbes B
Eur J Pharm Biopharm; 2009 Feb; 71(2):318-24. PubMed ID: 18845252
[TBL] [Abstract][Full Text] [Related]
3. Drug transport across pulmonary epithelial cell monolayers: effects of particle size, apical liquid volume, and deposition technique.
Bur M; Huwer H; Muys L; Lehr CM
J Aerosol Med Pulm Drug Deliv; 2010 Jun; 23(3):119-27. PubMed ID: 20073555
[TBL] [Abstract][Full Text] [Related]
4. Functional similarity of modified cascade impactor to deposit drug particles on cells.
Kumar V; Bariwal J; Narang AS; Tso J; Cheong J; Mahato RI
Int J Pharm; 2020 Jun; 583():119404. PubMed ID: 32387312
[TBL] [Abstract][Full Text] [Related]
5. Respiration-based measurement of lung deposition of a fluorescent dextrane aerosol in a marmoset monkey.
Bergers WW; van de Meent-van der Horst D; Joosen MJ
Inhal Toxicol; 2004 Mar; 16(3):141-6. PubMed ID: 15204775
[TBL] [Abstract][Full Text] [Related]
6. Alteration in Intrapulmonary Pharmacokinetics of Aerosolized Model Compounds Due to Disruption of the Alveolar Epithelial Barriers Following Bleomycin-Induced Pulmonary Fibrosis in Rats.
Togami K; Chono S; Tada H
J Pharm Sci; 2016 Mar; 105(3):1327-34. PubMed ID: 26886341
[TBL] [Abstract][Full Text] [Related]
7. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
Kolanjiyil AV; Kleinstreuer C; Sadikot RT
Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
[TBL] [Abstract][Full Text] [Related]
8. In vitro, ex vivo and in vivo methods of lung absorption for inhaled drugs.
Sakagami M
Adv Drug Deliv Rev; 2020; 161-162():63-74. PubMed ID: 32763274
[TBL] [Abstract][Full Text] [Related]
9. Effect of Heat Moisture Exchanger on Aerosol Drug Delivery and Airway Resistance in Simulated Ventilator-Dependent Adults Using Jet and Mesh Nebulizers.
Ari A; Dang T; Al Enazi FH; Alqahtani MM; Alkhathami A; Qoutah R; Almamary AS; Fink JB
J Aerosol Med Pulm Drug Deliv; 2018 Feb; 31(1):42-48. PubMed ID: 28829202
[TBL] [Abstract][Full Text] [Related]
10. Dry powder aerosol delivery systems: current and future research directions.
Chan HK
J Aerosol Med; 2006; 19(1):21-7. PubMed ID: 16551211
[TBL] [Abstract][Full Text] [Related]
11. Comparative performance of two inhaler systems to assess distribution of convective ventilation by 99mTc-labeled aerosol scintigraphy in patients with airway obstruction.
Fazzi P; Borsò E; Albertelli R; Mariani G; Giuntini C
Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):428-36. PubMed ID: 19174757
[TBL] [Abstract][Full Text] [Related]
12. One (sub-)acinus for all: Fate of inhaled aerosols in heterogeneous pulmonary acinar structures.
Hofemeier P; Koshiyama K; Wada S; Sznitman J
Eur J Pharm Sci; 2018 Feb; 113():53-63. PubMed ID: 28954217
[TBL] [Abstract][Full Text] [Related]
13. Lung deposition and respirable mass during wet nebulization.
Sangwan S; Condos R; Smaldone GC
J Aerosol Med; 2003; 16(4):379-86. PubMed ID: 14977428
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the generation of radiolabeled monodisperse albuterol particles using the spinning-top aerosol generator.
Usmani OS; Biddiscombe MF; Underwood SR; Barnes PJ
J Nucl Med; 2004 Jan; 45(1):69-73. PubMed ID: 14734675
[TBL] [Abstract][Full Text] [Related]
15. Monolayers of human alveolar epithelial cells in primary culture for pulmonary absorption and transport studies.
Elbert KJ; Schäfer UF; Schäfers HJ; Kim KJ; Lee VH; Lehr CM
Pharm Res; 1999 May; 16(5):601-8. PubMed ID: 10349999
[TBL] [Abstract][Full Text] [Related]
16. Aerosolized drug delivery: fractional deposition of inhaled particles.
Bennett WD
J Aerosol Med; 1991; 4(3):223-7. PubMed ID: 10147680
[TBL] [Abstract][Full Text] [Related]
17. In vitro cell integrated impactor deposition methodology for the study of aerodynamically relevant size fractions from commercial pressurised metered dose inhalers.
Haghi M; Traini D; Young P
Pharm Res; 2014 Jul; 31(7):1779-87. PubMed ID: 24549816
[TBL] [Abstract][Full Text] [Related]
18. The AERX aerosol delivery system.
Schuster J; Rubsamen R; Lloyd P; Lloyd J
Pharm Res; 1997 Mar; 14(3):354-7. PubMed ID: 9098880
[TBL] [Abstract][Full Text] [Related]
19. Aerosolized protein delivery in asthma: gamma camera analysis of regional deposition and perfusion.
Sangwan S; Agosti JM; Bauer LA; Otulana BA; Morishige RJ; Cipolla DC; Blanchard JD; Smaldone GC
J Aerosol Med; 2001; 14(2):185-95. PubMed ID: 11681650
[TBL] [Abstract][Full Text] [Related]
20. Large porous particle impingement on lung epithelial cell monolayers--toward improved particle characterization in the lung.
Fiegel J; Ehrhardt C; Schaefer UF; Lehr CM; Hanes J
Pharm Res; 2003 May; 20(5):788-96. PubMed ID: 12751635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
